OpenAI launches Rosalind Biodefense, expanding trusted access to GPT-Rosalind for vetted developers and U. S.
Machine-generated by The Flow from the publisher's headline and feed description — not written or checked by a human. The full article lives at OpenAI Blog.
OpenAI introduces GPT-Rosalind, a frontier reasoning model built to accelerate drug discovery, genomics analysis, protein reasoning, and scientific research workflows.
GPT-Rosalind advances life sciences research with enhanced biological reasoning, medicinal chemistry expertise, genomics analysis, and experimental workflow capabilities.
An action plan for AI-powered biological resilience
The OpenAI Foundation announces plans to invest at least $1 billion in curing diseases, economic opportunity, AI resilience, and community programs.
Our goal is to facilitate the development of AI-powered cybersecurity capabilities for defenders through grants and other support.
OpenAI previews GPT-5. 6 Sol, a next-generation model with stronger capabilities in coding, science, and cybersecurity, paired with its most advanced safety stack.